Range Capital Acquisition II, a blank check company targeting capital-constrained sectors, filed on Monday with the SEC to raise up to $200 million in an initial public offering.
The Cold Spring Harbor, NY-based company plans to raise $200 million by offering 20 million units at a price of $10. Each unit contains one share of common stock and one-half of one warrant exercisable at $11.50. At the proposed deal size, the company would command a market cap of $273 million.
The company is being led by CEO Tim Rotolo, who founded and currently serves as CEO of Lloyd Harbor Capital Management, and is also the CEO and Chairman of Range Capital Acquisition (Nasdaq: RANGU), and CFO Andrew Kucharchuk, who currently serves as CFO of Cero Therapeutics (Nasdaq: CERO), and Theralink Technologies (OTC: THER). The SPAC plans to target undervalued assets in capital constrained markets, including niche markets.
Range Capital Acquisition II was founded in 2024 and plans to list on the Nasdaq under the symbol RNGTU. BTIG is the sole bookrunner on the deal.
